NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 332 filers reported holding NATERA INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,474,858 | +1.4% | 55,929 | +11.5% | 0.00% | 0.0% |
| Q2 2023 | $2,441,126 | -11.9% | 50,167 | +0.5% | 0.00% | 0.0% |
| Q1 2023 | $2,772,336 | +39.6% | 49,934 | +1.0% | 0.00% | 0.0% |
| Q4 2022 | $1,986,125 | +7.7% | 49,443 | +17.5% | 0.00% | 0.0% |
| Q3 2022 | $1,844,000 | +122.7% | 42,079 | +80.2% | 0.00% | +100.0% |
| Q2 2022 | $828,000 | -7.1% | 23,353 | +6.6% | 0.00% | 0.0% |
| Q1 2022 | $891,000 | -64.3% | 21,914 | -17.9% | 0.00% | -50.0% |
| Q4 2021 | $2,493,000 | -10.2% | 26,690 | +7.1% | 0.00% | -33.3% |
| Q3 2021 | $2,777,000 | +12.2% | 24,916 | +14.3% | 0.00% | 0.0% |
| Q2 2021 | $2,474,000 | +21.9% | 21,792 | +9.0% | 0.00% | +50.0% |
| Q1 2021 | $2,030,000 | +14.5% | 19,990 | +12.2% | 0.00% | 0.0% |
| Q4 2020 | $1,773,000 | +110.6% | 17,819 | +53.0% | 0.00% | +100.0% |
| Q3 2020 | $842,000 | +97.2% | 11,649 | +36.1% | 0.00% | 0.0% |
| Q2 2020 | $427,000 | – | 8,557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |